Lamivudine’s hypersensitivity in an HIV infected patient: case report
Relevance: To report a case of hypersensitivity to lamivudine, a medicine that is considered safe and is indicated as part of the initial therapy for HIV infected patients. Comments: It is reported the evolution of an HIV patient who developed a drug eruption due to the following antirretroviral the...
Main Authors: | Vitor R. G. A. Valviesse, Leonardo I. de Pinho, Rodrigo F. Freitas, Andrea G. Varon, Alberto S. Lemos |
---|---|
Format: | Article |
Language: | Portuguese |
Published: |
Universidade de São Paulo
2017-04-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.revistas.usp.br/rmrp/article/view/135128 |
Similar Items
-
Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
by: Zamora FJ, et al.
Published: (2019-10-01) -
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice
by: Alberto Borghetti, et al.
Published: (2019-01-01) -
Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation
by: Kashif U Khan, et al.
Published: (2017-01-01) -
The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection
by: A V Kravchenko, et al.
Published: (2014-11-01) -
Switching to Dolutegravir + Lamivudine in a Highly Treatment-Experienced Patient Living with Human Immunodeficiency Virus Infection
by: Deniz GÖKENGİN, et al.
Published: (2022-12-01)